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INTRODUCTION
Universal newborn hearing screening (UNHS) is now performed 
worldwide because of the significant harm of unidentified per-
manent congenital hearing loss. These hearing screening pro-
grams have shown benefits for newborns and the Joint Commit-
tee on Infant Hearing (JCIH) has renewed up-to-date guidelines 
for hearing screening using automated auditory brainstem re-
sponse (AABR) and/or evoked otoacoustic emission (EOAE) (1, 
2). These protocols, performed according to the JCIH guidelines, 
have yielded successful results (3-7).
  Among the drawbacks of UNHS is the excessive number of 
false positives (i.e., normal ears falsely found to have hearing 
loss) detected using these protocols. About 60-80% of infants 
referred for further testing were found to be false positives, in-
creasing the rates of medical interventions (3-6). Thus, it is im-
portant to reduce the referral rate itself as much as possible. Be-
cause UNHS protocols using AABR generally have lower refer-
ral rates and better positive predictive values than protocols us-
ing EOAE, many institutions utilize AABR protocols (5-7). 
  Another concern of these screening protocols is the possibility 
of a change in hearing status after screening protocol. Infants 
with late onset hearing loss would not be detected by UNHS, 
suggesting that infants with risk indicators proposed by the JCIH 
should be rescreened (1). Furthermore, although few follow-up 
audiology studies after confirmation of congenital hearing loss 
have been performed, some studies reported children with con-
genital permanent sensorineural hearing loss undetected with 
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newborn hearing screening (8, 9). Conversely, infants with con-
firmed hearing loss showing later improvements in hearing were 
reported (10).
  How to confirm congenital hearing loss after newborn screen-
ing is another issue. Conventional click air conduction auditory 
brainstem response (ABR) has been used as a diagnostic meth-
od in many previous studies (3-6). Since conventional click ABR 
may give limited information in differentiation between perma-
nent and temporary, or sensorineural and conductive hearing 
loss, use of bone conduction ABR in evaluation of failed new-
born hearing screening has been reported (8, 11, 12). We have 
operated a newborn hearing screening program using staged 
AABR since 2004 with conventional click ABR testing, which is 
considered to be examined in terms of feasibility with extended 
follow-up.
  We therefore investigated the validity of newborn hearing scre-
ening method using AABR, click ABR testing and tympanome-
try protocol and we also evaluated changes in hearing status of 
infants with confirmed congenital hearing loss.
MATERIALS AND METHODS
Screening and confirmation protocol
We retrospectively reviewed the results of the UNHS process of 
neonates in the well-baby nursery of Asan Medical Center from 
March 2004 to December 2009. Our study protocol was ap-
proved by the Institutional Review Boards. We included only 
healthy babies and excluded those treated in or transferred to 
the neonatal intensive care unit (NICU). Of the 12,193 healthy 
babies born during this period, 10,879 (89.22%) were screened 
by AABR (ALGO3; Natus Medical Inc., San Carlo, CA, USA) 
while asleep and within 24 hours of birth by educated nursing 
personnel in the nursery. The AABR screener uses a 35 dB nHL 
alternating polarity click sound to assess the neural response of 
the auditory nerve. The AABR screener provides a pass-refer re-
sult without any need of interpretation. A retest performed im-
mediately after an incomplete result on the initial test was con-
sidered part of the initial test. For staged rescreening, infants 
who failed the previous screening were again tested by AABR 
on the day prior to discharge.
  All subjects referred from the hearing screening were recom-
mended to undergo diagnostic testing within 3 months after dis-
charge, as well as to undergo a physical examination by otolar-
yngologists. A conventional click ABR (Navigator, Biologic Co., 
Mundelein, IL, USA) with tympanometry (GSI Tympstar, Gra-
son-Stadler, Eden Prairie, MN, USA) at a frequency of 226 Hz 
were performed by audiologists. For the diagnostic testing, sleep 
was induced with chlorohydrate syrup (50 mg/kg), electrodes 
were applied to the forehead and mastoid region, and ABR us-
ing click sound was measured. Hearing level was defined as the 
minimal level resulting in a V wave with filtered click sound. In-
fants with ABR thresholds above 30 dB nHL in the diagnostic 
testing were considered to have abnormal hearing, with thresh-
olds less than 45 dB nHL defined as mild hearing loss, thresh-
olds ≥45 dB nHL and <70 dB nHL defined as moderate hear-
ing loss, thresholds ≥70 dB nHL and <90 dB nHL defined as 
severe hearing loss, and thresholds of ≥90 dB nHL or no ABR 
response to 90 dB nHL defined as profound hearing loss. 
Follow-up evaluation and rehabilitation 
Subsequent to the diagnostic test, a follow-up ABR before 6 mon-
ths of age was recommended for subjects with abnormal diag-
nostic ABR results from at least one ear. Babies with bilateral 
ABR thresholds over 45 dB nHL on follow-up ABR were rec-
ommended to use hearing aids for auditory rehabilitation. All 
subjects with abnormal diagnostic test results, including infants 
with unilateral hearing loss or bilateral mild hearing loss, were 
recommended to undergo regular serial follow-up ABR and 226 
Hz tympanometry at 3-6 month intervals. Changes in the hear-
ing status of each subject were analyzed with regard to follow-
up ABR results. Cochlear implantation was recommended for 
babies with bilateral profound hearing loss at 1 year of age.
RESULTS
AABR screening and diagnostic ABR results
Of the 10,879 neonates initially screened by staged AABR, 148 
(1.36%) were “referred”. Of these, parents of 117 neonates 
Fig. 1. Flowchart and outcomes of newborn hearing screening with 
staged automated auditory brainstem response (AABR). *Number 
of infants with true positive ear in at least 1 ear. 
†Number of infants 
with bilateral false positive ears. ABR, auditory brainstem response; 
HL, hearing loss.
10,879 newborn babies
Refer 148 (1.36%)
Follow-up 117 (1.08%)
Bilateral HL 12 Unilateral HL 2 Bilateral HL 9 Unilateral HL 22
Bilateral AABR “refer” 14 Unilateral AABR “refer” 31
True positive 45* False positive 72
†
Staged AABR screening
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(79.05%) agreed to diagnostic ABR testing, tympanometry and 
examination by otolaryngologists (Fig. 1). Forty five infants show-
ed diagnostic ABR thresholds over 30 dB nHL in at least one 
ear and all except 1 had a type-A tympanogram on the affected 
side; the remaining subject had a flat type-B tympanogram and 
middle ear effusion on physical examination. The other 72 of 
117 infants showed normal thresholds bilaterally on diagnostic 
ABR. The positive predictive value of AABR screening was there-
fore 38.46% (45/117). Of 45 infants with hearing loss, 14 were 
scored as “refer” in both ears (Fig. 1); of these, 12 had abnormal 
ABR results in both ears and 2 had abnormal results in only one 
ear. Twenty two infants showed abnormal ABR results on the 
“referred” side and normal thresholds on the “pass” side. Nine 
infants with unilateral AABR “refer” showed bilateral hearing 
loss (hearing thresholds over 30 dB nHL) during diagnostic ABR 
and type-A tympanogram. Thus, 24 infants had unilateral and 
21 had bilateral abnormal ABR results (Table 1).
Follow-up ABR results
Of 45 subjects with hearing loss in diagnostic ABR, 34 infants 
(75.6%) were assessed by follow-up ABR at least once. The mean 
length of follow-up was 18.0 months (range, 4 to 48 months) and 
21 infants were followed up for over 1 year after birth. We rec-
ommended that the hearing status of the 11 infants who did not 
undergo follow-up ABR at our center be monitored and man-
aged at other centers. Eleven of 34 (32.4%) showed bilateral 
normal hearing status at follow-up ABR and thresholds of the 
other 23 (67.6%) remained abnormal throughout their follow-
up ABR testing. Two of these infants received ventilation tube 
insertion at 10 and 11 months of age, respectively, due to persis-
tent middle ear effusion. Of the 9 infants with unilateral AABR 
“refer” and bilateral hearing loss on diagnostic ABR, 8 showed 
normal hearing threshold on follow-up ABR. The other one in-
fant was lost to follow-up.
Relationship between severity of diagnostic ABR and result of 
follow-up ABR
All 6 subjects with mild hearing loss at diagnostic ABR were 
found to be bilaterally normal on follow-up (Fig. 2). Five of 9 
subjects with moderate hearing loss were determined as having 
normal hearing, whereas the other 4, who showed abnormal 
thresholds at last follow-up. Bilateral ventilation tube insertion 
at the age of 6 months was needed in one subject with bilateral 
moderate hearing loss. Of the 11 subjects with normal hearing 
on follow-up testing, 10 showed normalization of hearing at 1 
year of age; the mean age of normalization in all 11 subjects 
was 10.3 months (range, 6 to 18 months). The 19 subjects (15 
unilateral and 4 bilateral hearing loss) with severe or profound 
hearing loss at diagnostic ABR remained having hearing loss on 
follow-up. Of these 19, 2 underwent ventilation tube insertion 
Table 1. Results of initial diagnostic auditory brainstem response (ABR) testing 
Severity Unilateral Bilateral* Total
Mild (ABR threshold<45 dB nHL)   4   8 (5)
† 12
Moderate (45 dB nHL≤ABR threshold<70 dB nHL)   4   6 (3)
† 10
Severe (70 dB nHL≤ABR threshold<90 dB nHL)   2   2 (1)
†   4
Profound (90 dB nHL≥ABR threshold or no ABR response to 90 dB nHL stimulus) 14   5 19
Total 24 21 (9)
† 45
*The severity of bilateral hearing loss was estimated relative to the ear with better hearing. 
†Numbers in parentheses indicates the number of infants with 
hearing loss who passed initial screening. 
Fig. 2. Relationship between the severity of diagnostic auditory brain  stem response (ABR) and the results of follow-up ABR. Mild, ABR thresh-
old<45 dB nHL; Moderate, 45 dB nHL≤ABR threshold<70 dB nHL; Severe, 70 dB nHL≤ABR threshold<90 dB nHL; Profound, ABR thresh-
old≥90 dB nHL or no ABR response to 90 dB nHL stimulus.
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and 5 were lost to follow-up before 1 year of age. The other 12 
subjects continued to show abnormal follow-up ABR results af-
ter 1 year of age.
  Of the 23 subjects with hearing loss on follow-up ABR, 3 
(13.0%) showed changes in severity of hearing loss at last fol-
low-up ABR. One infant with severe unilateral hearing loss and 
1 with moderate bilateral hearing loss improved to moderate 
unilateral and mild bilateral hearing loss, respectively. One in-
fant with moderate unilateral hearing loss progressed to severe 
hearing loss during follow-up, but he also had middle ear effu-
sion in the affected ear. We performed cochlear implantations 
for 3 babies with bilateral profound hearing loss and prescribed 
hearing aids for 3 babies with bilateral moderate to severe hear-
ing loss in this study cohort.
DISCUSSION
We screened 90% of healthy newborns for UNHS over a period 
of about 6 years, with nearly 80% of referred neonates followed 
up for confirmation. Although our protocol did not reach a cap-
ture rate of 95% or a follow-up rate of 90%, the quality indica-
tors of the JCIH in 2007, we consider our rates remarkable for 
Korea, a country where newborn hearing screening is not fully 
supported by the national health insurance service (1). The re-
ferral rate was 1.36%, with 45 true positives and 72 false posi-
tives identified through the screening protocol. Thus, of over 
10,000 infants screened, 0.41% was true positives of screening 
results, and the positive predictive value of our protocol was 
38.46%, both of which are acceptable and comparable with oth-
er studies (3-7, 10). Thirteen infants (0.12%) had greater than 
moderate hearing loss bilaterally, requiring hearing rehabilita-
tion; this incidence of congenital hearing loss was similar to those 
shown previously (3-7, 10).
  Follow-up ABR was performed to assess the initial diagnostic 
ABR result and the accuracy of the first diagnosis. Of 34 infants 
followed up serially, about one-third had normal hearing status 
during follow-up ABR, indicating that the cases, initially regard-
ed as having hearing loss judged by diagnostic ABR, were actu-
ally normal in hearing. Moreover, of the subjects with hearing 
loss on diagnostic ABR, some infants showed changes in severity 
of hearing loss on follow-up ABR. Such normalization of hear-
ing or changes in severity of hearing loss was noticeable in sub-
jects with mild or moderate hearing loss. Of the 6 subjects with 
mild hearing loss on diagnostic ABR, none had hearing loss on 
follow-up and only 4 of 9 subjects with moderate hearing loss 
on diagnostic ABR were found to have hearing loss finally. In 
contrast, subjects with severe or profound hearing loss on diag-
nostic ABR showed relatively robust results on follow-up.
  One of the possible causes of the change of hearing level may 
be related to the middle ear inflammation. Considering the inci-
dence of middle ear effusions in infancy is estimated to be as 
high 61%, subjects with middle ear effusion can be involved in 
our study population (13). Actually, middle ear opacity on high 
resolution computed tomography (HRCT) has been reported in 
about 40% of infants with bilateral hearing loss of more than 
50 dB identified by newborn hearing screening (10). Another 
possible explanation of hearing improvement can be delayed 
auditory pathway maturation. Talero-Gutierrez et al. (14) report-
ed spontaneous recovery of hearing threshold in children around 
1 year of age. 
  The key point of distinguishing temporary hearing loss due to 
middle ear effusion from permanent congenital hearing loss is 
complete evaluation for middle ear pathology. For this purpose, 
we used otoscopic examination and 226 Hz tympanometry which 
have substantial limitation for clear conclusion. Physical exami-
nation of the tympanic membrane in infants may be inaccurate 
due to technical difficulties, such as narrow ear canals, the pres-
ence of cerumen, and the lack of cooperation, and may also con-
tribute to a misdiagnosis of middle ear effusion (15, 16). Fur-
thermore, a study of infants less than 7 months old demonstrat-
ed that the result of tympanometry is often normal in the pres-
ence of middle ear effusion (17). In addition, standard 226 Hz 
tympanometry may not be appropriate for hearing screening in 
infants less than 6 months of age because of its incorrect and 
unreliable results and the JCIH has recommended that these in-
fants be screened by 1,000 Hz tympanometry (1, 18, 19). If tem-
porary middle ear effusion resolved during follow-up, follow-up 
ABR would show normal results. Because we performed only 
air conduction click ABR testing and 226 Hz tympanometry 
throughout follow-up, it might not be able to detect middle ear 
effusion in considerable number of subjects. Thus, undetected 
middle ear effusion at the time of diagnostic ABR may explain 
our temporary hearing loss findings.
  In addition, we identified 9 ears that passed initial AABR scre-
ening and proved as having hearing loss on diagnostic ABR. Since 
none of these infants was suspected of having middle ear effu-
sion at the time of diagnostic ABR, they could be regarded as 
having undetected congenital hearing loss which could threaten 
the feasibility of newborn hearing screening protocols. However, 
because all the patients except one showed normal hearing dur-
ing follow-up and one of these patients was follow-up loss, there 
was no false negative case found in our series.
  Change of hearing thresholds on follow-up ABR testing draws 
attention to the need of clear discrimination of type of hearing 
loss at the time of diagnostic testing. Many previous studies have 
concentrated on methods and results of the screening procedure 
and provided less information about the confirmation method 
and how to they clearly exclude the temporary conductive hear-
ing loss (3-6). As seen in this study, however, conventional click 
ABR and 226 Hz tympanometry are not enough to evaluate all 
possible hearing conditions. Some recent studies implemented 
bone conduction click or tone burst ABR with/without 1,000 Hz 
tympanometry in evaluation of failed newborn hearing screening Lim HW et al.: Audiological Follow-up after Newborn Hearing Screening     61
and it can bring proper early diagnosis by distinguishing amongst 
permanent sensorineural hearing loss, permanent conductive 
hearing loss, and temporary conductive hearing loss (8, 11, 12). 
  JCIH guidelines have emphasized that hearing interventions 
be performed before 6 months of age, and there is increasing in-
terest in the benefits of auditory rehabilitation for unilateral or 
mild bilateral hearing loss (1, 20, 21). Excessive false positive 
cases due to middle ear effusions can result in additional unnec-
essary medical interventions, put an emotional burden of par-
ents and lower the specificity and positive predictive value of 
the screening method. Our results indicate that hearing status at 
the time of diagnostic testing is uncertain with conventional click 
ABR and 226 Hz tympanometry, especially in cases of mild to 
moderate hearing loss and raise the need for implementation of 
more tools for bone conduction and middle ear evaluation to 
clarify whether temporary hearing loss of our study is tempo-
rary conductive or sensorineural hearing loss. 
  Taken together, the referral rate and the positive predictive 
value of our protocol were acceptable. We have also found here 
that substantial temporary hearing loss can be included in the 
first confirmative diagnosis. Temporary hearing loss of our study 
on follow-up give emphasis to need of further differentiation us-
ing the testing for bone conduction and middle ear status. Com-
plete evaluation of type and severity of hearing loss is important 
to avoid excessive burden from follow-up and to provide proper 
early intervention for permanent hearing loss.
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